A study in the Journal of the American Chemical Society reports steps toward making inhalable mRNA medicines a possibility.
Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...
Nov 12 (Reuters) - Novavax (NVAX.O), opens new tab cut its annual revenue forecast on Tuesday, citing lower-than-expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback